INNOGEN-B(02591) intends to reward the Caina Technology incentive program.

date
22:36 01/06/2026
avatar
GMT Eight
Yinuo Pharmaceuticals -B (02591) announced that the board of directors has recommended adopting a stock incentive plan. According to the detailed regulations of the organization's charter, a special resolution will be presented at the annual general meeting of shareholders to consider and approve the proposed adoption of the plan. The plan will only come into effect after approval by shareholders at the annual general meeting scheduled for June 29, 2026.
INNOGEN-B (02591) announcement states that the board of directors has proposed a reward plan for Caina Technology. According to the provisions of the organization's bylaws, a special resolution will be presented at the annual general meeting of shareholders to review and approve the proposed plan. The plan must be approved by the shareholders at the annual general meeting scheduled for June 29, 2026 to take effect. The purpose of the plan is to enhance the company's incentive mechanism by granting rewards to attract, motivate, and retain selected employees, employees of related entities, and service providers of the company, thereby further increasing the participants' enthusiasm and creativity. Participants under the plan should be motivated to serve the company in a better and more stable manner in the long term, create value, contribute to the continuous growth of the company's performance, and bring value-added benefits to the participants while enhancing the company's value, thereby achieving the mutual development of the participants and the company.